SweetValueLab
Write for us

Cencora, Inc. — Financial Statements & Ratios

COR
NYSEHealthcareMedical - DistributionCIK 0001140859cencora.comAbout COR
Last close · Oct 16, 2026340.92−0.49 (−0.14%)
Market cap$65.1B

Key indicators

Revenue332.8BTTM+5.1% on a year earlier+9.7% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
167.9B 179.6B+6.9%189.9B+5.7%214.0B+12.7%238.6B+11.5%262.2B+9.9%294.0B+12.1%321.3B+9.3%332.8B+5.1%337.1B 352.1B 368.6B
— 6.9% 5.7% 12.7% 11.5% 9.9% 12.1% 9.3% 5.1% 4.9% 4.4% 4.7%
$7.53 $4.04−46.3%-$16.65−512.1%$7.39+144.4%$8.04+8.8%$8.53+6.1%$7.53−11.7%$7.96+5.7%$13.47+38.6%$17.89 $19.76 $21.80
Profitability
2.7% 2.9%+0.1 pt2.7%−0.1 pt3.2%+0.5 pt3.5%+0.2 pt3.4%−0.1 pt3.4%−0.0 pt3.6%+0.2 pt4.0%+0.5 pt· · ·
0.9% 0.6%−0.2 pt-2.7%−3.3 pt1.1%+3.8 pt1.0%−0.1 pt0.9%−0.1 pt0.7%−0.2 pt0.8%+0.1 pt0.9%+0.0 pt· · ·
1.0% 0.5%−0.5 pt-1.8%−2.3 pt0.7%+2.5 pt0.7%−0.0 pt0.7%−0.0 pt0.5%−0.2 pt0.5%−0.0 pt0.8%+0.2 pt· · ·
56.5% 29.7%−26.8 pt334.5%+304.8 pt689.5%+354.9 pt-803.0%−1492.5 pt334.3%+1137.3 pt233.6%−100.7 pt103.1%−130.6 pt— · · ·
Cash
1.1B 2.0B+89.2%1.8B−9.7%2.2B+21.3%2.2B−1.0%3.5B+56.5%3.0B−13.2%3.2B+7.0%4.1B+255.7%· · ·
0.6% 1.1%+0.5 pt1.0%−0.2 pt1.0%+0.1 pt0.9%−0.1 pt1.3%+0.4 pt1.0%−0.3 pt1.0%−0.0 pt1.2%+0.9 pt· · ·
333.0M 339.0M+1.8%343.6M+1.4%366.6M+6.7%391.7M+6.8%398.8M+1.8%416.2M+4.4%437.1M+5.0%— · · ·
Balance sheet
1.47x 1.45x−0.02x-4.04x−5.49x29.93x+33.97x-26.96x−56.88x9.17x+36.13x6.79x−2.38x5.08x−1.71x3.84x−0.32x· · ·
220.34M 211.84M−3.9%204.78M−3.3%208.47M+1.8%211.21M+1.3%204.59M−3.1%200.28M−2.1%195.21M−2.5%193.94M−0.7%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.